Braskem’s restructuring sits at the intersection of finance, operations, bankruptcy law and Brazilian politics. We gave the same public record to four adversarial stakeholder agents and asked where, if anywhere, their interests overlap.
That makes the creditor coalition constructive on the EJ process, though final economics and individual Elliott/Contrarian signatures remain unconfirmed.
MODELED FINAL TERM SHEET
This is the hard clearing package selected by Run 5—not a summary of what remains open. It gives creditors priced PIK, equity upside, cash controls and permanent deleveraging if the operating recovery fails. It gives Braskem two years of cash-interest relief and avoids an immediate principal haircut. These are forecasted settlement terms; the filed plan does not say the parties agreed them.
A Brazilian placeholder case. More than one-third of each affected group is enough to file and get about 90 days. A finished plan later needs more than half.
A full court case if the out-of-court path fails. Shareholders can still keep leftover equity.
The model extends 2026–2034 maturities by exactly five years. The filed standstill does not contain that final treatment.
For 24 months the company pays 4% cash. The rest of each contractual coupon is added to principal. After that, the contractual coupon plus 1.50 percentage points is paid in cash.
The 24 August filing is a standstill. The five-year extension, 17.5% warrants and US$1.0B conversion backstop are Run 5’s forecast of a clearing package, not disclosed agreed terms.
If year-end 2028 net leverage remains above 5.0×, up to US$1.0B of debt converts at an independently determined equity value. That is the model’s hard deleveraging remedy.
The filed schedule contradicts the presumed-hostile creditor chair: the ad hoc bondholder group supplied most of the 39.6% coalition. Run 5 now selects one negotiated package instead of presenting open ranges. Public terms remain open; the model result is five years, two-year partial PIK, 17.5% warrants and a US$1.0B conversion backstop.
The complete current Run 5 record separates confirmed group-level process support from unconfirmed individual fund signatures.
READ THE RUN 5 RECORD ↗BACKGROUND
Braskem remains an important operating company, but years of industrial pressure and exceptional liabilities weakened the balance sheet before a short-term financing problem became acute.
Brazil’s Geological Survey linked ground movement in parts of Maceió to Braskem’s rock-salt mining. The company stopped mining and entered relocation, compensation and remediation agreements. By June 2026 it reported R$14.6 billion disbursed and a remaining provision of about R$3.2 billion, with residual legal uncertainty.
Q2 interim statements, Notes 1 and 23 ↗New global capacity, especially in Asia, grew faster than demand. Lower industry operating rates compressed resin and chemical spreads. Braskem still had productive assets, but the cycle reduced recurring cash generation while interest and Alagoas payments continued.
Q2 presentation, industry outlook ↗Braskem hired Lazard, Cleary Gottlieb and E. Munhoz to assess restructuring alternatives. In October it drew a US$1.0 billion standby facility maturing in December 2026. Ratings fell, reserve requirements rose, and access to supplier-finance arrangements narrowed.
Q2 interim statements, going-concern discussion ↗Shine I, advised by IG4, acquired Novonor’s controlling block and entered a joint-control agreement with Petrobras. The ownership transition introduced a new sponsor, but did not itself refinance Braskem or resolve how shareholders and creditors would share the burden.
June 5 ownership filing ↗The company sought five extra years on the debt, interest added to the balance instead of paid in cash, and renewed letter-of-credit capacity. Creditors rejected the economics and demanded shareholder support, compensation and the option to take security over assets. Braskem obtained a 60-day Brazilian stay and Chapter 15 protection. After cure periods expired in July, it reported defaults under certain financial instruments.
June 25 proposals and creditor response ↗A supply shock lifted Q2 recurring EBITDA to US$1.043 billion. Working capital consumed US$547 million because prices and inventory rose while payment arrangements tightened. The price and inventory effects are largely a one-time level reset if naphtha and volumes stabilize. The loss of supplier finance and LC capacity is more persistent.
Q2 earnings release ↗Braskem Idesa filed a prepackaged Chapter 11 to cut about US$920 million of senior debt while keeping operations running and Braskem in control. The parent contribution is US$476 million, of which about US$350 million is still due. That is a live use of Braskem S.A. liquidity, not a restatement of the existing intercompany term loan and working-capital facilities, and it does not reduce the US$10.3 billion corporate stack that Brazilian creditors are negotiating.
August 18 Material Fact ↗MEXICO · 18 AUG 2026
On 18 August Braskem confirmed that Braskem Idesa reached a consensual restructuring with its shareholders, term-loan lender and a substantial majority of noteholders, and commenced prepackaged Chapter 11 cases in the Southern District of Texas. Operations continue. Braskem remains the majority owner. This is not a Braskem S.A. filing.
All four simulation agents independently said the same thing: ring-fence Idesa, run a separate Chapter 11, and do not fold Mexican project debt into Braskem S.A. That is what happened. The 2029s and 2032s stay in their own estate. Trade is unimpaired. Emergence is targeted in 60 to 90 days. There is no disclosed parent guarantee of the remaining US$1.6 billion.
The published model treated Mexico as no new parent cash beyond the existing term loan and US$82 million secured working-capital facility. The Material Fact is a US$476 million contribution, of which about US$126 million was already in. The remaining US$350 million is a live cheque. The term-loan lender is listed as a separate supporting party, so that loan is not the equity contribution being relabeled.
The US$10.3 billion corporate stack, 6.74× leverage and December standby are unchanged. Idesa was already outside that corporate number. Consolidated IFRS debt falls if the haircut is real. That is optics. It does not roll letters of credit, restore supplier finance or change the parent coupon.
Mexico contributed US$57 million of Q2 EBITDA at 43% utilization. The remaining US$1.6 billion is underwritten on running the plant, not on that quarter. Braskem called Idesa a strategic asset and is paying to keep majority equity. That is an option on utilization, bought with scarce Brazil cash six days before the parent stay expires.
Model status: Run 4 still treats the remaining about US$350 million as parent cash the company has to spend. Cutting Idesa’s own debt does not cut Braskem S.A.’s US$10.3 billion. Idesa money is company cash, not an IG4 recapitalization of the parent.
NEGOTIATION TIMELINE
Company filings confirm the process and selected terms. News reports fill in private developments but often rely on unnamed sources, so each entry is labeled.
Braskem hired Lazard, Cleary Gottlieb and E. Munhoz to review its capital structure. Bondholders began organizing with their own advisers.
Bloomberg reported that deteriorating liquidity had led Braskem to consider a precautionary injunction or broader judicial protection.
Braskem sought one-third creditor support before July payments. The initial concept stretched maturities, cut coupons and added payment holidays, but offered no shareholder capital or debt conversion. IG4 then installed a restructuring-focused management team alongside Petrobras.
The company proposed five extra years on the debt, a 2.00 percentage-point coupon cut, and the option to add interest to the balance through December 2028 instead of paying it in cash. Creditors rejected the economics.
The creditor group called the proposal unsatisfactory and required better economics, meaningful shareholder contributions, cash controls and direct Petrobras participation. It was willing to support a temporary out-of-court filing with creditor protections. Elliott and SVP were reported as debt buyers.
Braskem rejected the AHG framework as unacceptable, opened Wind Chamber mediation and obtained a 60-day Brazilian stay against enforcement by invited financial creditors.
Braskem and five financing subsidiaries filed Chapter 15 cases in New York. The court granted provisional protection while recognition issues continued.
Times Brasil reported that Petrobras was studying support as an alternative to RJ and had increased its advisory involvement. Petrobras did not announce a commitment.
Valor reported two alternatives: DIP financing that could convert into equity and reduce controllers below 10%, or maturity extensions at existing coupons secured by substantially all assets. Braskem rejected the reported terms but confirmed receiving nonbinding proposals. Creditors also sought direct Petrobras talks.
Braskem confirmed that proposals included possible capitalization and asset security, but said they remained indicative and nonbinding. Bracebridge-affiliated funds separately challenged protection for Braskem America Finance in the US case.
Valor reported that the controllers had unofficially accepted RJ as a fallback. Braskem responded that no judicial or extrajudicial course had been selected and negotiations continued.
Braskem still described the creditor proposals as indicative and nonbinding, with capitalization and collateral under review. It also disclosed that certain financial instruments were in default after the July cure period expired.
Valor reported that Petrobras had put capped commercial support on the table, potentially extending payment terms on naphtha purchases currently made in cash for up to six months. The reported goal is to secure one-third creditor support for a stopgap EJ before 24 August and gain another 90 days to negotiate. The format, cap and creditor agreement were not final.
Fitch placed Braskem at RD. An out-of-court or court filing is expected to take the rating to D. That cost now attaches to a placeholder filing, not only to a full court case.
Braskem Idesa reached a consensual restructuring with its shareholders, term-loan lender and a substantial majority of noteholders, then filed Chapter 11 petitions in the Southern District of Texas. Senior debt is to fall from about US$2.5 billion to about US$1.6 billion. Braskem will contribute US$476 million, of which about US$126 million was already funded, and will remain the majority owner. Operations continue. The Mexican estate is separate from Braskem S.A.’s Brazilian stay and Chapter 15 cases.
Pipeline reported that Tuesday’s meeting with bondholders still had no Petrobras or IG4 capital injection. Creditors asked Petrobras to put money in if leverage or liquidity missed tests, as the price of supporting an out-of-court filing. That backstop was not agreed. The report is unnamed-source color, not a filing.
O Globo reported that Braskem is preparing an out-of-court filing for next week, with no asset sales in the first papers and 90 days to write a plan. The headline overstates creditor support. A placeholder filing still needs more than one-third of each affected group. Court approval of a finished plan is a later vote.
Braskem and five financing affiliates filed an EJ covering about US$10.9 billion of unsecured financial claims, with 39.6% initial support. The plan is a 90-day standstill: the detailed proposal is due 31 August, an in-person creditor/shareholder meeting by 9 September, and agreement in principle by 9 October. Final economics, shareholder support and equitization remain open.
The commercial limit rises from R$350M to R$2.35B through year-end. It is secured by client receivables, escrow and CIDE-credit rights, and is subject to conditions and Petrobras suspension rights. This is operating liquidity, not equity or an unsecured-creditor backstop.
Status at 27 August 2026: Braskem has filed the EJ with 39.6% support and has 90 days to obtain a majority for an updated plan. Petrobras’ R$2.35B facility is secured commercial liquidity. No final economics, irrevocable shareholder equity cheque or final majority support is public.
CURRENT ESTIMATE
Model judgment as of 27 August 2026. These are not company guidance, creditor positions or market-implied probabilities.
| Outcome | Probability | Likely structure | Equity read-through |
|---|---|---|---|
| Updated EJ with capital / equitization | 34% | Extension and relief paired with contingent shareholder capital or negotiated debt/equity conversion | Meaningful dilution; residual value depends on valuation and allocation |
| Updated EJ through extension / PIK | 23% | Five-year extension, 24 months at 4% cash plus residual PIK, contractual coupon +150bp afterward, controls and credit enhancement | Less dilution, but debt grows during the relief period |
| Cure and refinance | 2% | Outside financing resolves the defaults and maturity wall without coercive restructuring | Least dilutive, but no such financing is public |
| Creditor-favorable control / secured new money | 7% | A more dilutive control transaction or materially secured rescue financing | High dilution or control transfer |
| Court restructuring | 34% | The signatory coalition cannot agree final loss allocation or obtain the last roughly 10.4 points | Severe impairment; not an automatic wipe |
Run 5 carries the site’s US$694 million Q3 EBITDA estimate. It assumes the US$531/t July/August spread proxy holds through Q3; the estimate is not company guidance and cash conversion is not assumed. Group-level bondholder process support is confirmed; individual Elliott and Contrarian signatures and all final economics remain unconfirmed.
METHOD
Each party has different information, incentives, legal constraints and political exposure. Their advisers are also likely using AI to summarize filings, test arguments and model scenarios.
That makes a public AI simulation worth trying. It cannot predict a private negotiation, but it can expose the assumptions, trade-offs and possible bargaining range in a form that others can challenge.
Debt maturities, LC capacity, working capital, petrochemical spreads, shareholder control, Alagoas, Mexico and election-year politics cannot be understood through a single headline.
A bullish company narrative and a creditor recovery analysis can both be internally coherent. Role separation forces each case to face an opponent with a different objective.
The package is a stress-tested estimate of where the parties might overlap. It is not a forecast, inside information or evidence that any party has accepted these terms.
MODEL AND PROCEDURE
Run 5, 27 August 2026. Four stakeholder roles use the disclosed signatory ad hoc bondholder coalition, the US$531/t Q3 spread assumption, the site’s US$694M Q3 EBITDA estimate and Petrobras’ secured R$2.35B trade-credit facility.
Petrobras, Braskem management, IG4 / Shine I and financial creditors each received a separate brief. First-round positions were formed before agents saw one another’s proposals. Creditors were told not to speak as one committee that would take 15% warrants.
After independent openings, the roles received the other proposals and completed two concession rounds. A mediator then tested packages against each party’s walk-away.
Public information through 27 August 2026, led by the filed EJ and negotiation framework, Petrobras’ secured commercial-credit disclosure, the June creditor record, Q2 filings and the separate Braskem Idesa case. Verified facts were separated from inference.
“Hostile” is retired as the current creditor label. The filed schedule confirms group-level process support but not individual Elliott or Contrarian signatures. Combined EJ outcomes are 57%; RJ remains 34% because final economics are unresolved.
Private term sheets, exact note holdings, undisclosed mandates, personal dynamics, current cash after the reporting date, or a party’s true walk-away point.
KEY FINDING
Q2’s US$547M working-capital outflow reflected both higher prices and inventory and worsening payment arrangements. The price and inventory component should not recur without another balance increase, but Braskem did not disclose the exact split and the cash remains tied up until balances reverse. LC runoff, reduced supplier financing, interest and maturities remain structural problems.
Interpretation: Q2 does not establish a structural 20% cash-conversion rate. Adding back the full US$547M produces about US$757M of recurring cash, but that is an illustrative sensitivity, not normalized cash flow or a forecast. Stable prices and inventory can improve conversion, while restoring financing terms remains necessary for full liquidity relief.
Higher feedstock and product prices, plus higher inventory volumes. These consume cash when balances rise and can reverse as inventory is sold or prices fall. Braskem did not quantify this portion separately.
LC expirations, lost reverse factoring, shorter supplier terms and bank reimbursement obligations persist even if naphtha prices stop rising.
RUN 5 · NEGOTIATION ROUNDS
Run 5 treats the creditor coalition as constructive on process and hard on economics. Round 3 is selected by default. Open Run 5 ↗
RUN 5 · AGENT SUMMARIES FOR ROUND 3 · LATEST
R$2.35B trade line; no equity cheque; accept the modeled covenant package
“The trade line keeps feedstock moving; it is not an equity cheque.”
Five-year extension · 4% cash / residual PIK · 17.5% creditor warrants
“The filing buys time; it does not complete the restructuring.”
Accept 17.5% dilution, stepping to 25%; preserve joint control
“Process support is not a blank cheque or automatic control surrender.”
Take priced PIK, warrants, cash controls and a US$1B conversion backstop
“We signed the process, not undefined economics.”
Latest result: updated EJ outcomes total 57%; RJ remains 34% because final economics are open
SENSITIVITY
Choose a sustainable annualized EBITDA run rate at the end-2028 valuation date.
The consensual structure becomes credible and warrants preserve creditor upside.
Timing and method: EBITDA is an annualized run rate at end-2028. It is not cumulative EBITDA over 2027 and 2028. BAK is modeled as an equity option at that date because extra years to maturity, or leftover equity in a court case, can leave shares with value even when enterprise value is below debt. The midpoint uses 5.0× EV/EBITDA, US$10.26B net debt after two years of unpaid interest added to the balance, three years to the extended maturity, 30% asset volatility, a 4.5% risk-free rate, two shares per ADR, equal economics across share classes and 17.5% warrant dilution. The range varies the multiple from 4.5× to 5.5× and volatility from 25% to 35%. It excludes intervening free cash flow, further cash burn and the 25% warrant step-up. This is scenario analysis, not a price target. A placeholder filing does not dilute shares until a finished plan is approved.
BAK SCENARIOS
BAK closed at $1.95 on 14 August 2026. Under the model’s midpoint assumptions, that price implies roughly $1.44B of sustainable annual EBITDA if the restructuring closes, or a better operating case discounted for failure.
REFRESH THE MARKET PRICE BEFORE USING THIS TABLE ↗TRACK PE–NAPHTHA SPREADS ↗| Annual EBITDA | PE minus naphtha | Effective domestic resin spreads | End-2028 BAK | Return from $1.95 | Interpretation |
|---|---|---|---|---|---|
| $1.5B | $300 to $400/t | PE $900 to $1,050/tPP $300 to $400/t | $2.24$1.09 to $3.65 | +15%+6% annualized | Normalization. Not enough upside for the restructuring risk. |
| $2.0B | $450 to $550/t | PE $1,050 to $1,200/tPP $400 to $500/t | $5.34$3.32 to $7.52 | +174%+53% annualized | Mid-cycle recovery. Attractive only after financing is committed. |
| $2.5B≈$625M/qtr | $600 to $700/t≈$600M/qtr maps here | PE $1,200 to $1,500/tPP $500 to $600/t | $9.36$6.62 to $12.18 | +380%+94% annualized | Strong spreads with sustained cash conversion. |
| $3.0B | $700 to $800/t | PE $1,500 to $1,750/tPP $600 to $650/t | $13.94$10.60 to $17.33 | +615%+129% annualized | Disruption regime near Q2 spreads, sustained beyond one quarter. |
| $4.0B | Above $800/t | PE above $1,750/tPP above $650/t | $23.92$19.53 to $28.34 | +1,127%+188% annualized | Requires broad global strength, high utilization and more than Brazil spreads alone. |
Spread calibration: Q2 2026 reported a $773/t benchmark, $1,739/t effective domestic PE spread, $1,198/t effective domestic PP–naphtha spread and $1.043B of quarterly EBITDA. The MZIQ plan modeled effective PE spreads of $1,088/t in Q3 and $971/t in Q4, with quarterly EBITDA of $586M and $351M. We use roughly $200M of annual EBITDA for each sustained $100/t change in the PE benchmark, then adjust for PP, chemicals, international operations, utilization and REIQ. Returns run through 31 December 2028 and exclude taxes, fees, dividends and ADR friction. Nonlinear scenario analysis, not company guidance or investment advice. Track live PE–naphtha and related spreads ↗ Q2 presentation ↗ Effective-price plan ↗
POSITION DISCLOSUREThe anonymous author who selected the source materials, designed the agent prompts and directed this analysis holds a long position in BAK. The author benefits if BAK rises and may buy or sell securities discussed here without notice. This analysis is not investment advice.
HORMUZ SCENARIO
If Hormuz remains effectively closed and PE minus naphtha spreads stay near current strong levels, our conditional central estimate is $2.7B of annual EBITDA, with a $2.5B to $2.9B range. Because the spread is measured after naphtha, higher feedstock cost is already reflected in that estimate. It can still create a one-time working-capital build, but should not repeat at the same scale unless input prices or inventory rise again. Trade routes can adapt, Chinese supply can respond and the Strait can partially normalize, which lowers the probability-weighted estimate to roughly $2.3B to $2.5B.
Middle Eastern naphtha and petrochemical flows remain disrupted. Shipping delays, feedstock costs and alternative Chinese supply determine how quickly the advantage fades. S&P supply analysis ↗ S&P H2 outlook ↗
Not investment advice. Forecasts and BAK values are scenario-model inferences, not management guidance or guarantees.
At $1.95, the $1.5B EBITDA case offers only 15% midpoint upside while its low range implies 44% downside. The pre-deal position is therefore an option on successful financing, not a conventional value investment.
The model becomes investable around the $2.0B EBITDA case only after a finished plan can be verified, not after a placeholder filing.
The $2.5B case should not be used until reported results support roughly $625M of average quarterly EBITDA and operating working capital is flat or reversing.
Distressed optionality. Consistent with roughly $1.5B annual EBITDA or a large probability of deal failure.
A funded restructuring and a credible path toward $2.0B annual EBITDA.
Evidence for the $2.5B case, including about $625M of average quarterly EBITDA and visible cash conversion.
A sustained $3.0B annual run rate, not one exceptional quarter.
BAK HOLDERS
A placeholder filing does not dilute BAK. Creditor warrants appear only if a finished plan is later approved. At 17.5% fully diluted warrants, every legacy holder retains 82.5% of their previous ownership percentage. The warrants rise to 25% only if agreed cash-conversion, liquidity, interest or extra Mexico cash tests are missed.
ADR holders have no vote. They ride IG4 if there is no conversion. The ADR wrapper matters only if a later cash rights offering preserves BRKM5 preemption but cannot include US ADS holders. That transaction has not been announced.
IMPORTANT DISCLOSURES
This material is general and impersonal. It does not consider any reader’s objectives, financial condition, portfolio, tax status, jurisdiction, liquidity needs or risk tolerance. It is not an offer, solicitation, fiduciary communication, individualized recommendation or substitute for licensed financial, legal and tax advice.
BAK and BRKM5 involve default, restructuring, dilution, liquidity, foreign-exchange, depositary, political and total-loss risk. Valuations and probabilities are hypothetical model outputs, not guarantees or promises of future performance. AI systems can misread sources, make arithmetic errors and produce persuasive but incorrect conclusions. Private negotiations and events after the public-information cutoff are outside the model.
Position disclosure: the anonymous author who selected the source materials, designed the agent prompts, directed revisions and publishes this site holds a long position in BAK. The author benefits if BAK rises and may buy or sell securities discussed here without notice. Do not assume this is independent research. Verify every material claim against the linked primary documents.
REFERENCES
The complete filing set used for the financial, legal and ownership baseline.
Method: Four stakeholder briefs, adversarial openings, two rounds of concessions, then a neutral mediator tested each package against realistic alternatives.
OPEN SOURCES, PROMPTS AND RUN FILES ↗KEY ASSUMPTIONS
These five assumptions have the largest effect on the model result.